◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › B › BAYN

Bayer Aktiengesellschaft (BAYN) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - General · DATA UPDATED 2026-08-16

Bayer Aktiengesellschaft (BAYN) operates in the Drug Manufacturers - General industry and is headquartered in Leverkusen, Germany with about 87,830 employees. Its market capitalization is roughly €47 billion. In the fiscal year ended 2025-12-31, BAYN reported €45.6B in revenue and (€3.6B) in net income.

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments.

Interactive charts & full statements →

BAYN Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-31
Total Revenue€45.6B€46.6B€47.6B€50.7B
Gross Profit€26.8B€25.3B€27.9B€30.9B
Operating Income (EBIT)€6.1B€3.3B€8.0B€7.3B
Net Income(€3.6B)(€2.6B)(€2.9B)€4.2B

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BAYN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue€10.9B€13.4B€11.4B€9.7B€10.7B——
Gross Profit€6.3B€8.2B€6.9B€5.4B€6.4B——
Operating Income (EBIT)€827M€3.5B€4.3B(€543M)€13M——
Net Income€219M€2.8B(€3.8B)(€963M)(€199M)——

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BAYN Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid(€127M)(€131M)(€2.4B)(€2.0B)—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BAYN Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Dividends Paid(€112M)—(€11M)(€8M)(€108M)—(€13M)

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BAYN Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-31
Total Assets€104.5B€110.8B€116.3B€124.9B
Total Liabilities€78.5B€78.8B€83.2B€86.0B

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BAYN viewer.

Other Companies in Drug Manufacturers - General

← BAXAll “B” companiesBB →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.